AI in pharma marketing and commercial teams

AI is in every pharma pitch, keynote and town hall. Yet most commercial teams use a fraction of the tools they already pay for, and most enterprise pilots never show up on the P&L. The gap is rarely the technology. It is adoption, ownership and the way the work is organized.

These perspectives cover how pharma marketing and commercial teams get real value from AI: choosing one workflow and one owner, managing the fear that stalls adoption, rethinking the brand plan, and why vendors win by leading with outcomes rather than the word AI.

Written by a practitioner who has deployed the platforms and led the teams, through Kairos Meridian, an independent pharma commercial consultancy.